Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression

BYLINE: Denise Heady Newswise — Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small…

Read more Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression

UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients.

Newswise — Irvine, CA – Sept. 11, 2023 – UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and neurodegeneration markers in people who suffer…

Read more UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients.